Literature DB >> 30032827

Patterns of care and emergency presentations for people with non-small cell lung cancer in New South Wales, Australia: A population-based study.

Sarsha Yap1, David Goldsbury2, Mei Ling Yap3, Susan Yuill1, Nicole Rankin4, Marianne Weber5, Karen Canfell6, Dianne L O'Connell7.   

Abstract

INTRODUCTION: Little is known about population-wide emergency presentations and patterns of care for people diagnosed with non-small cell lung cancer (NSCLC) in Australia. We examined patients' characteristics associated with presenting to an emergency department around the time of diagnosis ("emergency presenters"), and receiving anti-cancer treatment within 12 months of diagnosis.
MATERIALS AND METHODS: Participants in the 45 and Up Study who were newly diagnosed with NSCLC during 2006-2010 were included. We used linked data from population-wide health databases including Medicare and pharmaceutical claims, inpatient hospitalisations and emergency department presentations to follow participants to June 2014. Patients' characteristics associated with being an emergency presenter and receiving any anti-cancer treatment were examined.
RESULTS: A total of 647 NSCLC cases were included (58.6% male, median age 73 years). Emergency presenters (34.5% of cases) were more likely to have a high Charlson comorbidity index score, be an ex-smoker who had quit in the past 15 years and to be diagnosed with distant metastases. Almost all patients had visited their general practitioner ≥3 times in the 6 months prior to diagnosis. Nearly one-third (29.5%) of patients did not receive any anti-cancer treatment, however, there were no differences between emergency and non-emergency presenters in the likelihood of receiving treatment. Those less likely to be treated were older, had no private health insurance, and had unknown stage disease recorded.
CONCLUSION: Our results indicate the difficulties in diagnosing lung cancer at an early stage and inequities in NSCLC treatment. Future research should address opportunities to diagnose lung cancer earlier and to optimise treatment pathways.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer treatment; Emergency presentation; Non-small cell lung cancer; Patterns of care

Mesh:

Year:  2018        PMID: 30032827     DOI: 10.1016/j.lungcan.2018.06.006

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  6 in total

1.  Pathways to diagnosis of non-small cell lung cancer: a descriptive cohort study.

Authors:  Stuart Purdie; Nicola Creighton; Kahren Maree White; Deborah Baker; Dan Ewald; Chee Khoon Lee; Alison Lyon; Johnathan Man; David Michail; Alexis Andrew Miller; Lawrence Tan; David Currow; Jane M Young
Journal:  NPJ Prim Care Respir Med       Date:  2019-02-08       Impact factor: 2.871

2.  Contributions of prognostic factors to socioeconomic disparities in cancer survival: protocol for analysis of a cohort with linked data.

Authors:  Xue Qin Yu; David Goldsbury; Sarsha Yap; Mei Ling Yap; Dianne L O'Connell
Journal:  BMJ Open       Date:  2019-08-18       Impact factor: 2.692

3.  Lung Cancer Pre-Diagnostic Pathways from First Presentation to Specialist Referral.

Authors:  Satya Rashi Khare; Sreenath Arekunnath Madathil; Gerald Batist; Isabelle Vedel
Journal:  Curr Oncol       Date:  2021-01-11       Impact factor: 3.677

Review 4.  Measuring Health Equity in Emergency Care Using Routinely Collected Data: A Systematic Review.

Authors:  Kevin Morisod; Xhyljeta Luta; Joachim Marti; Jacques Spycher; Mary Malebranche; Patrick Bodenmann
Journal:  Health Equity       Date:  2021-12-01

5.  Socioeconomic disparities in colorectal cancer survival: contributions of prognostic factors in a large Australian cohort.

Authors:  Xue Qin Yu; David Goldsbury; Eleonora Feletto; Cherry E Koh; Karen Canfell; Dianne L O'Connell
Journal:  J Cancer Res Clin Oncol       Date:  2021-11-25       Impact factor: 4.322

6.  Factors associated with emergency-related diagnosis, time to treatment and type of treatment in 5713 lung cancer patients.

Authors:  Yngvar Nilssen; Odd T Brustugun; Bjørn Møller
Journal:  Eur J Public Health       Date:  2021-10-26       Impact factor: 3.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.